← Eichor
Condition: Heart Failure With Preserved Ejection Fraction Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Heart Failure With Preserved Ejection Fraction

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Safety, Tolerability, and Biomarker Trial of VS-041 in Participants With Heart Failure With Preserved Ejection Fractio
Phase 1 · 21 location(s) · Vasa Therapeutics · NCT07219511Feasibility and Effectiveness of Eccentric Exercise in Sarcopenic Older Adults with Heart Failure: a Pilot Study
NA · 2 location(s) · Universita di Verona · NCT06826963Beta-blocker Discontinuation in Heart Failure With Preserved Ejection Fraction
NA · 1 location(s) · UConn Health · NCT05174351Cardiovascular and Renal Endpoints With Flozins - an Observational Prospective Study in CKD HFpEF Patients
Phase N/A · 1 location(s) · Grigore T. Popa University of Medicine and Pharmacy · NCT07237451Exercise Magnetic Resonance Imaging in Patients With Obesity Associated Heart Failure
Phase N/A · 1 location(s) · University Medical Center Groningen · NCT06514820A Phase II Clinical Trial of HRS-1893 in the Treatment of Heart Failure With Preserved Ejection Fraction
Phase 2 · 1 location(s) · Shandong Suncadia Medicine Co., Ltd. · NCT07269717Catheter Ablation in Atrial Fibrillation Patients With HFpEF (STABLE-SR IV Trial)
NA · 1 location(s) · The First Affiliated Hospital with Nanjing Medical Universit · NCT06125925SHort Of Pace - Heart Failure (SHOP-HF)
NA · 1 location(s) · Fundación para la Investigación del Hospital Clínico de Vale · NCT06992089Left Bundle Branch Pacing vs Right Ventricular Pacing on AHRE Burden in Patients With Preserved LVEF
NA · 1 location(s) · University Hospital of Patras · NCT07250529Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure With Preserved Ejection Fraction
Phase 3 · 78 location(s) · Uppsala University · NCT02901184The PeriCut Catheter System Early Feasibility Study (REIMAGINE-HFpEF)
NA · 1 location(s) · Heart Failure Solutions, Inc. · NCT06702501Cardiomyopathies and Heart Muscle Diseases: Cardiac Imaging in the Evaluation of Myocardial Fibrosis Transition
Phase N/A · 1 location(s) · University of Edinburgh · NCT06409585Bariatric Surgery Evaluation and Assessment of Treatment Efficacy - Intervention Trial
NA · 2 location(s) · University Medical Center Groningen · NCT06065124ELEVATE-HFpEF Clinical Study
NA · 46 location(s) · Medtronic Cardiac Rhythm and Heart Failure · NCT06678841Endovascular Ablation of the Right Greater Splanchnic Nerve in Subjects Having HFpEF
NA · 20 location(s) · Axon Therapies, Inc. · NCT04592445A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)
Phase 2 · 142 location(s) · Pfizer · NCT06991257Copenhagen Heart Failure With Preserved Ejection Fraction
Phase N/A · 1 location(s) · Tor Biering-Sørensen · NCT06685237LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
Phase 3 · 92 location(s) · Tenax Therapeutics, Inc. · NCT07288398Provocative Tests for HFpEF
Phase N/A · 1 location(s) · Istituto Auxologico Italiano · NCT06309550Exercise Cardiovascular Magnetic Resonance In Heart Failure With Preserved Ejection Fraction
Phase N/A · 1 location(s) · Mayo Clinic · NCT07401771Matching Perfusion and Metabolic Activity in HFpEF
Phase 2 · 1 location(s) · University of Pennsylvania · NCT04913805New Orleans Pulmonary Hypertension Biobank
Phase N/A · 1 location(s) · Louisiana State University Health Sciences Center in New Orl · NCT03269630Effect of Dapagliflozin on Metabolomics and Cardiac Mechanics in Chronic Kidney Disease
Phase 1/Phase 2 · 1 location(s) · Northwestern University · NCT05719714Pioglitazone on Heart Failure in Type-2 Diabetes Mellitus Participants
Phase 4 · 1 location(s) · The University of Texas Health Science Center at San Antonio · NCT05838287Prevalence and Prediction of ATTR in Ambulatory Patients With HFpEF
NA · 1 location(s) · Massachusetts General Hospital · NCT05577819Multiple-biomarker Approach for Individualized Treatment of Heart Failure with Preserved Ejection Fraction
Phase N/A · 6 location(s) · Erasmus Medical Center · NCT06785506Determination of the Prevalence of Unrecognized Heart Failure Among Patients at Risk in Urban Areas Across Germany Using
Phase N/A · 1 location(s) · German Heart Institute · NCT07185100A Study of 68Ga-Fibroblast Activation Protein Inhibitor (FAPI) Positron Emission Tomography in Heart Failure
Phase 2 · 1 location(s) · Mayo Clinic · NCT07083011HeartShare: Combining Omics, Deep Phenotyping, and Electronic Health Records for Heart Failure Subtypes and Treatment Ta
Phase N/A · 6 location(s) · Northwestern University · NCT05873634Atrioventricular Node Ablation and Conduction System Pacing in Patients With Well Controlled Permanent Atrial Fibrillati
NA · 15 location(s) · French Cardiology Society · NCT06833138
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.